A molecular diagnostic test for guiding cancer treatment selection and predicting therapeutic drug response. Utilizes DNA methylation analysis to optimize personalized cancer treatment strategies.
Manufactured by
China
Singlera Genomics is a China-based manufacturer of in vitro diagnostic (IVD) reagents and instruments specializing in DNA methylation-based cancer early detection and liquid biopsy testing. The company produces diagnostic products for multiple cancer types including colorectal, liver, gastric, esophageal, and pancreatic cancers, with manufacturing facilities in Yangzhou and Wuxi. Singlera holds ISO 13485 certification, CAP accreditation, US CLIA laboratory certification, and is designated as a National High-tech Enterprise in China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
guangzhou biotron technolongy co.,ltd
China · 2 relevant products
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 5 relevant products
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 5 relevant products
Acon Biotech (Hangzhou) Co., Ltd.
China · 3 relevant products
shanghai rendu biotechnology co.,ltd.
China · 1 relevant product
Diatech Pharmacogenetics srl
Italy · 3 relevant products
CheMOnitor Ltd.
Hungary · 1 relevant product
BIOTYPE GmbH
Germany · 2 relevant products
HLB PANAGENE Co., Ltd.
South Korea · 2 relevant products
i Med Laboratories Co., Ltd.
Thailand · 1 relevant product
54 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 91 closest product alternatives
guangzhou biotron technolongy co.,ltd · China
Molecular diagnostic system tracking circulating tumor cell dynamics and nucleic acid markers to evaluate cancer treatment efficacy and guide therapeutic decisions.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test for monitoring therapeutic response and detecting minimal residual disease in cancer patients. Supports ongoing treatment optimization and prognosis assessment.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
In vitro diagnostic test for identifying genetic biomarkers that predict treatment response in cancer patients. Guides selection of targeted therapies and treatment protocols.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test providing precise tumor subtyping for improved treatment stratification. Supports personalized oncology management and therapeutic decision-making.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for cancer detection and tumor marker analysis. Supports early detection of various cancer types.
shanghai rendu biotechnology co.,ltd. · China
Specialized molecular test for monitoring therapeutic efficacy through detection and quantification of messenger RNA. This test supports treatment response assessment and therapeutic adjustment in clinical practice.
Diatech Pharmacogenetics srl · Italy
Molecular testing service for monitoring deep response in chronic myeloid leukemia patients from diagnosis through treatment follow-up. Utilizes genomic sequencing and variant analysis to track disease progression and treatment effectiveness.
CheMOnitor Ltd. · Hungary
An in vitro diagnostic blood test designed to predict chemotherapy effectiveness in lung cancer patients at an early stage, before full treatment cycles are completed. The test analyzes N-glycan profiles using ultra-high resolution glycomics combined with AI-based data interpretation to provide oncologists with actionable treatment response predictions.
BIOTYPE GmbH · Germany
A molecular diagnostic test for detecting ESR1 mutations in tumor diagnostics. Used for biomarker analysis in cancer precision medicine.
HLB PANAGENE Co., Ltd. · South Korea
A diagnostic test for NRAS mutation detection in melanoma and other cancers, supporting personalized cancer treatment selection.
i Med Laboratories Co., Ltd. · Thailand
Diagnostic test for detection of cancer biomarkers in blood and body secretions. Identifies biomolecules produced and released by cancer cells for screening and monitoring purposes.
HLB PANAGENE Co., Ltd. · South Korea
A diagnostic assay for TERT promoter mutation detection in various cancer types including glioblastoma and melanoma.
79 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products